GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Icon PLC (NAS:ICLR) » Definitions » Total Liabilities

Icon (ICLR) Total Liabilities

: $7,749 Mil (As of Dec. 2023)
View and export this data going back to 1998. Start your Free Trial

Icon's Total Liabilities for the quarter that ended in Dec. 2023 was $7,749 Mil.

Icon's quarterly Total Liabilities declined from Jun. 2023 ($8,311.22 Mil) to Sep. 2023 ($8,072.46 Mil) and declined from Sep. 2023 ($8,072.46 Mil) to Dec. 2023 ($7,749.12 Mil).

Icon's annual Total Liabilities declined from Dec. 2021 ($9,320.26 Mil) to Dec. 2022 ($8,687.32 Mil) and declined from Dec. 2022 ($8,687.32 Mil) to Dec. 2023 ($7,749.12 Mil).


Icon Total Liabilities Historical Data

The historical data trend for Icon's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Icon Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,289.46 1,585.37 9,320.26 8,687.32 7,749.12

Icon Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Liabilities Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8,687.32 8,632.67 8,311.22 8,072.46 7,749.12

Icon Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Icon's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2825.608+(3791.76+217.914
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+899.1+14.738)
=7,749

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=16989.863-9240.743
=7,749

Icon's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2825.608+(3791.76+217.914
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+899.1+14.738)
=7,749

Total Liabilities=Total Assets (Q: Dec. 2023 )-Total Equity (Q: Dec. 2023 )
=16989.863-9240.743
=7,749

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Icon Total Liabilities Related Terms

Thank you for viewing the detailed overview of Icon's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Icon (ICLR) Business Description

Traded in Other Exchanges
Address
South County Business Park, Leopardstown, Dublin, IRL, D18 X5R3
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.